Researcher
Ann Smeets
- Disciplines:Morphological sciences, Oncology, Orthopaedics, Surgery, Nursing
Affiliations
- Surgical Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 10
- iSurvive-Mind Helpt het geheugen van (ex-)kankerpatiëntenFrom1 May 2023 → TodayFunding: Provinces
- The enigma of subjective lymphedema: Why do patients report lymphedema after breast cancer treatment without an objective measurable swelling? The role of sensory processing and subclinical lymphedema – LymphSens TrialFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Impact of adiposity and lifestyle on breast cancer biology and treatment response.From7 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From25 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From1 Oct 2021 → TodayFunding: BOF - projects
- Connecting Single-cell Immune Profiling in Peripheral Blood with Intratumoral T Cell Expansion in Breast Cancer Upon Checkpoint ImmunotherapyFrom24 Aug 2021 → TodayFunding: FWO Strategic Basic Research Grant
- A mindfulness-based intervention as candidate to reduce cognitive impairment and recover brain changes after breast cancer treatment.From2 Jan 2019 → 1 Jan 2024Funding: FWO Strategic Basic Research Grant
- What causes cognitive decline after treatment for breast cancer? A multiparametric neuroimaging studyFrom4 Sep 2017 → 14 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancerFrom1 Oct 2016 → 15 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
111 - 120 of 151
- Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?(2013)
Authors: Ann Smeets, Annouschka Laenen, Hans Wildiers, Robert Paridaens, Chantal Van Ongeval, Beppe Floris, Patrick Neven, Rose Christiaens
- Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer(2013)
Authors: Ann Smeets, Andries Ryckx, Ann Belmans, Hans Wildiers, Patrick Neven, Beppe Floris, Patrick Schöffski, Rose Christiaens
Pages: 480 - Sentinel lymph node involvement in ductal carcinoma in-situ of the breast: two different causes(2012)
Authors: Ann Smeets, Robert Paridaens, Rose Christiaens, Beppe Floris, Philippe Moerman, Patrick Neven
Pages: 378 - 381 - Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers(2012)
Authors: Annouschka Laenen, Joke Vanderhaegen, Hans Wildiers, Karin Leunen, Frédéric Amant, Ann Smeets, Robert Paridaens, Rose Christiaens, Beppe Floris, Philippe Moerman, et al.
Pages: 2578 - 2584 - 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium(2012)
Authors: Diether Lambrechts, Ann Smeets, Robert Paridaens, Caroline Weltens
Pages: 1783 - 1791 - Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome and genetic determinants of vitamin D insufficiency(2012)
Authors: Sigrid Hatse, Diether Lambrechts, Mieke Verstuyf, Ann Smeets, Annouschka Laenen, Lieve Verlinden, Anne-Sophie Dieudonné, Robert Paridaens, Patrick Neven, Rose Christiaens, et al.
Pages: 1319 - 1326 - Proteolytic Processing of ErbB4 in Breast Cancer(2012)
Authors: Hans Wildiers, Ann Smeets, Patrick Schöffski
- Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors : an uncontrolled experimental study with 24 weeks of follow-up(2012)
Authors: Ben Van Calster, Karin Leunen, Ann Smeets, Frédéric Amant, Hans Wildiers, Robert Paridaens, Erik Van Limbergen, Caroline Weltens, Hilde Janssen, Stéphanie Peeters, et al.
Pages: 1449 - 1454 - The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause(2012)
Authors: Jacquie Chirgwin, Zhuoxin Sun, Ian Smith, Karen N Price, Beat Thürlimann, Bent Ejlertsen, Hervé Bonnefoi, Meredith M Regan, Aron Goldhirsch, Alan S Coates, et al.
Pages: 295 - 306 - Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning(2012)
Authors: Sabine Deprez, Frédéric Amant, Ann Smeets, Ronald Peeters, Wim Van Hecke, Rose Christiaens, Joris Vandenberghe, Mathieu Vandenbulcke, Stefan Sunaert
Pages: 274 - 281